Skip to main content
Joseph Tucci, MD, Endocrinology, Providence, RI, Memorial Hospital of Rhode Island

JosephRalphTucciMD

Endocrinology • Providence, RI

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Thyroid

Professor, Medicine, Boston University School of Medicine

Join to view full profile

Dr. Tucci is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tucci's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1965 - 1967
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1964 - 1965
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1962 - 1964
  • St Elizabeth's Medical Center
    St Elizabeth's Medical CenterResidency, Internal Medicine, 1960 - 1962
  • St Elizabeth's Medical Center
    St Elizabeth's Medical CenterInternship, Transitional Year, 1959 - 1960
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1959

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 1969 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook
  • Fellow (FACE) American Association of Clinical Endocrinology

Publications & Presentations

PubMed

Press Mentions

  • Effect of Alendronate and MK-677 (A Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women
    Effect of Alendronate and MK-677 (A Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic WomenJuly 22nd, 2020
  • Huffing Dust Spray: Bone Disease Adds up to Its Adverse Effects
    Huffing Dust Spray: Bone Disease Adds up to Its Adverse EffectsOctober 6th, 2016

Hospital Affiliations

Dr. Joseph Tucci, Dr. Joseph Tucci, MD, Dr. J Tucci, Dr. Joseph Ralph Tucci